No Data
10-Q: Q3 2026 Earnings Report
ResMed Expects FY 2026 Gross Margin of 62%-63% as It Plans $175M+ Q4 Buybacks and Targets June 1 Close for $340M Noctrix Deal
8-K: Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
RESMED INC CDI COM USD0.004 (10CDI/1SHS) To Go Ex-Dividend On February 11th, 2026 With 0.06 USD Dividend Per Share
January 30th (Eastern Time) - $RESMED INC CDI COM USD0.004 (10CDI/1SHS)(RSMDF.US)$ is trading ex-dividend on February 11th, 2026.Shareholders of record on February 12th, 2026 will receive 0.06 USD
10-Q: Q2 2026 Earnings Report
ResMed Outlines 62%–63% Gross Margin Target for Fiscal 2026 Amid Double-digit Growth in Key Segments